Meeting Report
Cardio-Oncology: The Intersection Between Cardiovascular Disease and Cancer
Presented by Jessica Shank Coviello, DNP, APRN, ANP-BC, and Kejal Amin, PharmD, MBA, BCOP
From (1)Yale University School of Nursing, New Haven, Connecticut; (2)Smilow Cancer Center, New Haven, Connecticut
J Adv Pract Oncol 2021;12(3):253–256 |
https://doi.org/10.6004/jadpro.2021.12.3.6 |
© 2021 Harborside™
ABSTRACT
Cardio-oncology is a rapidly emerging field, and advanced practitioners (APs) play key roles in the prevention, early detection, and optimal treatment of cardiotoxicities associated with cancer therapies. At JADPRO Live Virtual 2020, Jessica Shank Coviello, DNP, APRN, ANP-BC, and Kejal Amin, PharmD, MBA, BCOP, reviewed patient risk factors and cardiovascular therapeutic agents that APs should be aware of.
For access to the full length article, please
sign in.
